The Liddy Shriver Sarcoma Initiative helping those dealing with sarcoma.                      HOME

Liddy's Story
Sarcomas
Clinical Trials
ESUN
Funded Research
Sarcoma Calendar
Initiatives
Personal Journeys
Links
News
Donations
Volunteer
First Time Visitors
Searching Our Website
Guest Book
Unknown Effect
Up
Bevacizumab
ET-743
ImmTher
Immunotherapy
mTOR Inhibitors
Perifosine
TRM (TRAIL)

mTOR Inhibitors

There are a number of studies underway investigating targeted cancer therapy that inhibits the activity of mTOR (mammalian Target Of Rapamycin), a cellular enzyme that plays a key role in cell growth and proliferation. An introduction to the issues involved can be found in McGurl D. From Easter Island Soil to Treating Sarcoma—Rapamycin Derivatives. ESUN 2005:Vol 2, No 2

 

Research Results

AP23573: A Review of Recent Results, by Drs. Chawla, Sankhala, Mita, and Tolcher, ESUN 2005:Vol.2, No.4